BTIG Maintains Buy on Boston Scientific, Raises Price Target to $93
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Marie Thibault has maintained a Buy rating on Boston Scientific (NYSE:BSX) and raised the price target from $84 to $93.
October 14, 2024 | 4:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BTIG analyst Marie Thibault has maintained a Buy rating on Boston Scientific and increased the price target from $84 to $93, indicating a positive outlook.
The increase in the price target from $84 to $93 by BTIG suggests a positive outlook for Boston Scientific, likely leading to a short-term increase in stock price as investors react to the analyst's confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100